Bioventus (BVS) Non Operating Income (2020 - 2026)
Bioventus' (BVS) quarterly Non Operating Income came in at -$3.9 million in Q1 2026, up 48.08% YoY from -$2.6 million in Q1 2025, and down 9.43% on a QoQ basis from -$3.6 million in Q4 2025.
Bioventus (BVS) Non Operating Income (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Non Operating Income data on file, last reported at -$3.9 million in Q1 2026.
- Quarterly Non Operating Income rose 48.08% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.7 million (up 36.67% YoY) and the FY2025 annual result came in at -$26.5 million, up 28.7% from the prior year.
- Non Operating Income slipped to -$3.9 million in Q1 2026, from -$3.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.5 million in Q2 2022 to a low of -$10.9 million in Q4 2023.
- A 5-year average of -$6.9 million and a median of -$7.8 million in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income slumped 622.97% — and 2025, when it jumped 54.06%.
- Tracing BVS's Non Operating Income over 5 years: stood at -$7.0 million in 2022, then slumped by 54.43% to -$10.9 million in 2023, then increased by 28.59% to -$7.8 million in 2024, then jumped by 54.06% to -$3.6 million in 2025, then decreased by 9.43% to -$3.9 million in 2026.
- The last three Non Operating Income figures came in at -$3.9 million (Q1 2026), -$3.6 million (Q4 2025), and -$6.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.83 Bn | 197.23 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.24 Bn | 122.76 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 119.38 Bn | 110.16 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.76 Bn | 47.51 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 35.12 Bn | 33.17 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | - |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Bioventus | 969.85 Mn | 940.39 Mn | 105.67 Mn | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -4.07 Mn |
| Mar 28, 2026 | -3.90 Mn |
| Dec 31, 2025 | -3.56 Mn |
| Sep 27, 2025 | -6.18 Mn |
| Jun 28, 2025 | -8.06 Mn |
| Mar 29, 2025 | -7.51 Mn |
| Dec 31, 2024 | -7.76 Mn |
| Sep 28, 2024 | -8.91 Mn |
| Jun 29, 2024 | -10.08 Mn |
| Mar 30, 2024 | -10.34 Mn |
| Dec 31, 2023 | -10.86 Mn |
| Sep 30, 2023 | -10.12 Mn |
| Jul 1, 2023 | -10.59 Mn |
| Apr 1, 2023 | -8.11 Mn |
| Dec 31, 2022 | -7.03 Mn |
| Oct 1, 2022 | -3.72 Mn |
| Jul 2, 2022 | -2.58 Mn |
| Apr 2, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Oct 2, 2021 | -1.35 Mn |